Onkos Surgical Gains FDA Clearance for ELEOS™ Proximal Tibia with NanoCept® Technology
Parsippany, N.J., October 21, 2025: Onkos Surgical®, a leader in complex orthopaedic innovation, has received U.S. FDA 510(k) clearance...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Parsippany, N.J., October 21, 2025: Onkos Surgical®, a leader in complex orthopaedic innovation, has received U.S. FDA 510(k) clearance...
EWING, N.J., August 19, 2025 — TheraBreath™, the best-selling alcohol-free mouthwash brand in the U.S., has introduced a new...
